New Memorial Sloan Kettering Cancer Center research reveals how dormant metastatic cancer cells protect themselves from the ...

Cancer cells that have broken away from a primary tumor can lurk in the body for years in a dormant state, evading immune ...

Cancer cells that have broken away from a primary tumor can lurk in the body for years in a dormant state, evading immune ...

Cancer cells that detach from a primary tumor can remain hidden in the body for years in a dormant state, avoiding immune ...

How the tobacco industry rebranded a brutally addictive drug from deadly to desirable—and what it means for our health.

The tobacco industry rebranded a brutally addictive drug from deadly to desirable—and the longer-term health consequences may ...

Dormant lung cancer cells change their shape from spindle shaped (above) to round (below), which helps protect them from the body's immune defenders.

Large cell carcinoma is aggressive, requiring early detection through imaging and biopsy for optimal treatment outcomes.

The early-stage clinical trial marks the first U.S. testing of Alveltamig, an immunotherapy designed to help the immune system better recognize and respond to small cell lung cancer. The study aims to ...

When lung cancer treatment stops working, what happens next? New research reveals the answer may depend on how the cancer grows.

A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor ...